Eintrag weiter verarbeiten
Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
Gespeichert in:
Zeitschriftentitel: | Arthritis & Rheumatism |
---|---|
Personen und Körperschaften: | , |
In: | Arthritis & Rheumatism, 31, 1988, 8, S. 1046-1051 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Wiley
|
Schlagwörter: |
author_facet |
Vitti, Gerard Hamilton, John A. Vitti, Gerard Hamilton, John A. |
---|---|
author |
Vitti, Gerard Hamilton, John A. |
spellingShingle |
Vitti, Gerard Hamilton, John A. Arthritis & Rheumatism Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid Pharmacology (medical) Immunology Rheumatology Immunology and Allergy |
author_sort |
vitti, gerard |
spelling |
Vitti, Gerard Hamilton, John A. 0004-3591 1529-0131 Wiley Pharmacology (medical) Immunology Rheumatology Immunology and Allergy http://dx.doi.org/10.1002/art.1780310817 <jats:title>Abstract</jats:title><jats:p>Previous studies have shown that mononuclear cell–conditioned medium (MCCM), interleukin‐1 (IL‐1), and all‐<jats:italic>trans</jats:italic>‐retinoic acid rapidly stimulate, while glucocorticoids lower, the urokinase‐type plasminogen activator (u‐PA) activity of human synovial fibroblastlike cells. It is now reported that MCCM, recombinant human IL‐1α (rHuIL‐1α), rHuIL‐1β, and all‐<jats:italic>trans</jats:italic>‐retinoic acid elevate the u‐PA messenger RNA (mRNA) levels to a steady‐state value within 2 hours, while dexamethasone (10<jats:sup>−7</jats:sup><jats:italic>M</jats:italic>) inhibits this increase. For both situations, when the u‐PA activity is either stimulated or reduced, the changes in the u‐PA mRNA levels parallel the changes in the u‐PA activity, and it is suggested that modulation of gene transcription plays an important role.</jats:p> Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid Arthritis & Rheumatism |
doi_str_mv |
10.1002/art.1780310817 |
facet_avail |
Online Free |
finc_class_facet |
Chemie und Pharmazie Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuMTc4MDMxMDgxNw |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuMTc4MDMxMDgxNw |
institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
imprint |
Wiley, 1988 |
imprint_str_mv |
Wiley, 1988 |
issn |
0004-3591 1529-0131 |
issn_str_mv |
0004-3591 1529-0131 |
language |
English |
mega_collection |
Wiley (CrossRef) |
match_str |
vitti1988modulationofurokinasetypeplasminogenactivatormessengerrnalevelsinhumansynovialfibroblastsbyinterleukin1retinoicacidandaglucocorticoid |
publishDateSort |
1988 |
publisher |
Wiley |
recordtype |
ai |
record_format |
ai |
series |
Arthritis & Rheumatism |
source_id |
49 |
title |
Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_unstemmed |
Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_full |
Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_fullStr |
Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_full_unstemmed |
Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_short |
Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_sort |
modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
topic |
Pharmacology (medical) Immunology Rheumatology Immunology and Allergy |
url |
http://dx.doi.org/10.1002/art.1780310817 |
publishDate |
1988 |
physical |
1046-1051 |
description |
<jats:title>Abstract</jats:title><jats:p>Previous studies have shown that mononuclear cell–conditioned medium (MCCM), interleukin‐1 (IL‐1), and all‐<jats:italic>trans</jats:italic>‐retinoic acid rapidly stimulate, while glucocorticoids lower, the urokinase‐type plasminogen activator (u‐PA) activity of human synovial fibroblastlike cells. It is now reported that MCCM, recombinant human IL‐1α (rHuIL‐1α), rHuIL‐1β, and all‐<jats:italic>trans</jats:italic>‐retinoic acid elevate the u‐PA messenger RNA (mRNA) levels to a steady‐state value within 2 hours, while dexamethasone (10<jats:sup>−7</jats:sup><jats:italic>M</jats:italic>) inhibits this increase. For both situations, when the u‐PA activity is either stimulated or reduced, the changes in the u‐PA mRNA levels parallel the changes in the u‐PA activity, and it is suggested that modulation of gene transcription plays an important role.</jats:p> |
container_issue |
8 |
container_start_page |
1046 |
container_title |
Arthritis & Rheumatism |
container_volume |
31 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792339351976280066 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T15:46:43.832Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Modulation+of+urokinase%E2%80%90type+plasminogen+activator+messenger+rna+levels+in+human+synovial+fibroblasts+by+interleukin%E2%80%901%2C+retinoic+acid%2C+and+a+glucocorticoid&rft.date=1988-08-01&genre=article&issn=1529-0131&volume=31&issue=8&spage=1046&epage=1051&pages=1046-1051&jtitle=Arthritis+%26+Rheumatism&atitle=Modulation+of+urokinase%E2%80%90type+plasminogen+activator+messenger+rna+levels+in+human+synovial+fibroblasts+by+interleukin%E2%80%901%2C+retinoic+acid%2C+and+a+glucocorticoid&aulast=Hamilton&aufirst=John+A.&rft_id=info%3Adoi%2F10.1002%2Fart.1780310817&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792339351976280066 |
author | Vitti, Gerard, Hamilton, John A. |
author_facet | Vitti, Gerard, Hamilton, John A., Vitti, Gerard, Hamilton, John A. |
author_sort | vitti, gerard |
container_issue | 8 |
container_start_page | 1046 |
container_title | Arthritis & Rheumatism |
container_volume | 31 |
description | <jats:title>Abstract</jats:title><jats:p>Previous studies have shown that mononuclear cell–conditioned medium (MCCM), interleukin‐1 (IL‐1), and all‐<jats:italic>trans</jats:italic>‐retinoic acid rapidly stimulate, while glucocorticoids lower, the urokinase‐type plasminogen activator (u‐PA) activity of human synovial fibroblastlike cells. It is now reported that MCCM, recombinant human IL‐1α (rHuIL‐1α), rHuIL‐1β, and all‐<jats:italic>trans</jats:italic>‐retinoic acid elevate the u‐PA messenger RNA (mRNA) levels to a steady‐state value within 2 hours, while dexamethasone (10<jats:sup>−7</jats:sup><jats:italic>M</jats:italic>) inhibits this increase. For both situations, when the u‐PA activity is either stimulated or reduced, the changes in the u‐PA mRNA levels parallel the changes in the u‐PA activity, and it is suggested that modulation of gene transcription plays an important role.</jats:p> |
doi_str_mv | 10.1002/art.1780310817 |
facet_avail | Online, Free |
finc_class_facet | Chemie und Pharmazie, Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuMTc4MDMxMDgxNw |
imprint | Wiley, 1988 |
imprint_str_mv | Wiley, 1988 |
institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
issn | 0004-3591, 1529-0131 |
issn_str_mv | 0004-3591, 1529-0131 |
language | English |
last_indexed | 2024-03-01T15:46:43.832Z |
match_str | vitti1988modulationofurokinasetypeplasminogenactivatormessengerrnalevelsinhumansynovialfibroblastsbyinterleukin1retinoicacidandaglucocorticoid |
mega_collection | Wiley (CrossRef) |
physical | 1046-1051 |
publishDate | 1988 |
publishDateSort | 1988 |
publisher | Wiley |
record_format | ai |
recordtype | ai |
series | Arthritis & Rheumatism |
source_id | 49 |
spelling | Vitti, Gerard Hamilton, John A. 0004-3591 1529-0131 Wiley Pharmacology (medical) Immunology Rheumatology Immunology and Allergy http://dx.doi.org/10.1002/art.1780310817 <jats:title>Abstract</jats:title><jats:p>Previous studies have shown that mononuclear cell–conditioned medium (MCCM), interleukin‐1 (IL‐1), and all‐<jats:italic>trans</jats:italic>‐retinoic acid rapidly stimulate, while glucocorticoids lower, the urokinase‐type plasminogen activator (u‐PA) activity of human synovial fibroblastlike cells. It is now reported that MCCM, recombinant human IL‐1α (rHuIL‐1α), rHuIL‐1β, and all‐<jats:italic>trans</jats:italic>‐retinoic acid elevate the u‐PA messenger RNA (mRNA) levels to a steady‐state value within 2 hours, while dexamethasone (10<jats:sup>−7</jats:sup><jats:italic>M</jats:italic>) inhibits this increase. For both situations, when the u‐PA activity is either stimulated or reduced, the changes in the u‐PA mRNA levels parallel the changes in the u‐PA activity, and it is suggested that modulation of gene transcription plays an important role.</jats:p> Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid Arthritis & Rheumatism |
spellingShingle | Vitti, Gerard, Hamilton, John A., Arthritis & Rheumatism, Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid, Pharmacology (medical), Immunology, Rheumatology, Immunology and Allergy |
title | Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_full | Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_fullStr | Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_full_unstemmed | Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_short | Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_sort | modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
title_unstemmed | Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid |
topic | Pharmacology (medical), Immunology, Rheumatology, Immunology and Allergy |
url | http://dx.doi.org/10.1002/art.1780310817 |